Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 4 October 2021
EventHumanCOVID-19
Bulgarian is available via eTranslation, the European Commission's machine translation service.
Translate to Bulgarian | Important information about machine translation
Date
- понеделник, 4 October 2021, Цял ден
Местоположение
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
This extraordinary meeting is organised in the context of the evaluation of an application for the use of:
- additional and booster doses for the COVID-19 vaccine Comirnaty;
- additional doses for the COVID-19 vaccine Spikevax.
The aim of the meeting is to conclude these evaluations, if possible.
This extraordinary meeting takes place within the monthly meeting of the Committee for Medicinal Products for Human Use (CHMP) for preparatory and organisational matters.
The CHMP is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.